NCT00004039View on ClinicalTrials.gov

Combination Chemotherapy Plus Interferon Alfa or Rituximab in Treating Patients With Stage III or Stage IV Lymphoma

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

June 30, 1998

Primary Completion Date

January 31, 2000

Study Completion Date

January 31, 2000

Conditions
Lymphoma
Interventions
BIOLOGICAL

recombinant interferon alfa

BIOLOGICAL

rituximab

DRUG

cyclophosphamide

DRUG

doxorubicin hydrochloride

DRUG

prednisone

DRUG

vincristine sulfate

Trial Locations (1)

92658

Hoag Memorial Hospital Presbyterian, Newport Beach

Sponsors
All Listed Sponsors
collaborator

Cancer Biotherapy Research Group

OTHER

lead

Hoag Memorial Hospital Presbyterian

OTHER

NCT00004039 - Combination Chemotherapy Plus Interferon Alfa or Rituximab in Treating Patients With Stage III or Stage IV Lymphoma | Biotech Hunter | Biotech Hunter